📰 Marc Feldmann News
Marc Feldmann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Marc Feldmann. Real-time updates on events, politics, business and more.
May 18, 2024
A concentrated formulation of adalimumab injected directly into the diseased tissue may be effective in targeting the cells responsible for Dupuytren's disease
January 18, 2024
Carbon Farming Germany has made groundbreaking progress in sustainable fuel production and developed BeyondZero, the worlds first CO2-negative biofuel. BeyondZero is the result of an innovative c ...
June 2, 2023
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt about the contents of this document or the action you should take, you... | June 2, 2023
May 24, 2023
Rockwell Medical (NASDAQ:RMTI – Get Rating) and 180 Life Sciences (NASDAQ:ATNF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings. Profitability This table compares Rockwell Medical and 180 […]
May 17, 2023
Rockwell Medical (NASDAQ:RMTI – Get Rating) and 180 Life Sciences (NASDAQ:ATNF – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Institutional & Insider Ownership 27.6% of Rockwell Medical […]
February 23, 2023
23.02.2023 - PALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) - 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a Notice of ... Seite 1
August 22, 2022
PALO ALTO, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company announced that the first patient
August 22, 2022
PALO ALTO, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage...
July 29, 2022
(2022-07-27 | NDAQ:ATNF) 180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp.